万维提示：
1、投稿方式：在线投稿。
2、官网网址：http://www.genesndiseases.com/
https://www.sciencedirect.com/journal/genes-and-diseases
3、投稿网址：https://www.editorialmanager.com/GENDIS
4、官网邮箱：editor@genesndiseases.com（编辑部）
5、官网电话：023-65714691（编辑部）
6、出刊日期：双月刊，逢单月出版。
2024年4月18日星期四
Genes & Diseases 融合出版官方网站上线啦！
【微信公众号“重庆医科大学（cqmu1956）”信息】
重庆医科大学 2023-12-19 15:12 重庆
Genes & Diseases 融合出版
官方网站上线
为了更好的服务广大专家和读者用户，提升用户使用体验，增加期刊与各位用户朋友的沟通与连接，经过前期精心策划和筹备以及不断修改和测试，在SD官方网站的基础上，Genes & Diseases自建官网经升级改版，推出全新融合出版中英文官方网站。新版网站于2023年12月7日正式成功上线，以全新的姿态和面貌迎接即将到来的创刊十周年。
新版官网从顺应互联网发展趋势，彰显期刊特色，完善功能、优化布局、增加互动等方面做了深度升级，同时突出以“图-文-视-听”四位一体的呈现形式，能够更方便快捷的浏览获取期刊论文、主题专辑、人物专访以及科普文章等资讯。
全新融合出版官网入口：
http://www.genesndiseases.com/
ScienceDirect官方网站：
https://www.sciencedirect.com/journal/genes-and-diseases
新网站，新风貌，在此衷心感谢各位专家和读者的关注和支持！期待在各位持续支持和关注下，Genes & Diseases 全新官方网站能够成为一个更好的交流互动平台。
《基因与疾病（英文）》投稿指南
【官网信息】
Guide for Authors
Introduction
About the Journal
Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, rapid communication, correspondence, perspectives, commentary, views on news, research watch, letters, research highlights, and enabling and emerging technologies.
Editorial Process
All manuscripts received are duly acknowledged. Upon submission, the Editorial Office will check the manuscript's conformity to technical quality and author guidelines, typically within one week. Manuscripts with insufficient conformity are returned to authors for revision. Manuscripts with insufficient originality, serious scientific or experimental flaws, or lack of interest to the readership of Genes & Diseases will be rejected by the Editor-in-Chief and/or Deputy Editor-in-Chief without further peer review. Manuscripts deemed suitable for publication are sent to the Executive Associate Editors. The Executive Associate Editors will make initial assessment and will serve as the managing editor, who in turn will appoint 2-3 editorial board members and/or external referees to complete peer reviews within 4 weeks. Based on the recommendations and comments made by peer reviewers, the Executive Associate Editor will make a formal recommendation to the Editor-in-Chief and/or Deputy Editor-in-Chief who will make the final decision within 1 week, in consultation with other editorial board members, if deemed necessary. The comments and recommendations (acceptance/ rejection/ minor revision/ major revision in manuscript) received from reviewers are conveyed to the corresponding author. If necessary, the author is required to provide a point by point response to reviewers' comments and submit a revised manuscript. This process will be repeated till reviewers and editors are satisfied with the revised manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 48 hours. The whole process of submission of the manuscript, final decision, sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as 'Ahead of Print' immediately upon acceptance.
During submission, the contributor is requested to provide names of at least three qualified reviewers who have had experience in the subject of the submitted manuscript. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor.
Contact Details for Submission
Papers should be submitted through the Genes & Diseases online submission system, https://www.editorialmanager.com/GENDIS. For questions on the submission and reviewing process, please contact the Editorial Office at: editor@genesndiseases.com; telephone +86-23-6571 4691.
更多详情请查看期刊官网信息。
